BDBM704817 N-[3-(3,5-dimethylisoxazol-4-yl)-4-[2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]heptan-5-yl]ethoxy]phenyl]-1-fluoro- cyclopropanecarboxamide::US20240376090, Compound 162

SMILES Cc1noc(C)c1-c1cc(NC(=O)C2(F)CC2)ccc1OCCN1C[C@@H]2C[C@H]1CO2

InChI Key InChIKey=LGZQJVXNJGGWPR-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 704817   

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM704817(N-[3-(3,5-dimethylisoxazol-4-yl)-4-[2-[(1S,4S)-2-o...)
Affinity DataKi:  4.70nMAssay Description:Radioligand binding assays were performed using [3H]5-HT as the radioligand using cell membranes prepared from HEK293 cells expressing recombinant 5-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
US Patent